Zaloguj Zarejestruj się zadarmo

Edesa Biotech organizacji Cel na 1 rok

Jaka jest wartość Cel na 1 rok organizacji Edesa Biotech?

Wartość Cel na 1 rok organizacji Edesa Biotech, Inc. to $16 +273.68%

Jaka jest definicja Cel na 1 rok?

Cel na 1 rok to przewidywana cena akcji za rok od dnia dzisiejszego.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

Cel na 1 rok firm w Health Care sektor na NASDAQ w porównaniu do Edesa Biotech

Czym się zajmuję organizacja Edesa Biotech?

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Firmy z cel na 1 rok podobne do Edesa Biotech